Search

Your search keyword '"Ankermann, Tobias"' showing total 195 results

Search Constraints

Start Over You searched for: Author "Ankermann, Tobias" Remove constraint Author: "Ankermann, Tobias"
195 results on '"Ankermann, Tobias"'

Search Results

2. Position paper dupilumab and vaccination

4. Non-CF-Bronchiektasien

5. Fremdkörperaspiration

6. Primäre ziliäre Dyskinesie (Primary Ciliary Dyskinesia, PCD)

8. Pneumothorax

9. Bronchiolitis obliterans

10. Atelektase

11. Fehlbildungen der Atemwege

12. Bronchopulmonale Dysplasie (BPD)

14. Einheitliche Basisversorgung von Kindern und Jugendlichen mit Long COVID: Stellungnahme einer multidisziplinären Arbeitsgruppe der DGKJ-Konvent-Gesellschaften (Stand: Februar 2022)

16. White paper on peanut allergy – part 1: Epidemiology, burden of disease, health economic aspects

17. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

18. 9 Erkrankungen der unteren Atemwege

19. Pädiatrisch relevante Arzneimittelinteraktionen

21. Arzneimitteltabellen für die Pädiatrie

23. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI

24. Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA)

29. High burden of acute respiratory tract infections leading to hospitalization at German pediatric hospitals: fall/winter 2022–2023.

32. Pathogen spectra in hospitalised and nonhospitalised children with community-acquired pneumonia

40. Divergent dynamics of inflammatory mediators and multiplex PCRs during airway infection in cystic fibrosis patients and healthy controls: Serial upper airway sampling by nasal lavage

41. Pathogen spectra in hospitalised and non-hospitalised children with community acquired pneumonia

42. Praktischer Umgang mit allergischen Reaktionen auf COVID-19-Impfstoffe

43. Schwere allergische Reaktionen nach COVID-19-Impfung mit dem Impfstoff von Pfizer/BioNTech in Großbritannien und USA

44. Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of German Allergologists (AeDA), Austrian Society of Allergology and Immunology (ÖGAI), Swiss Society for Allergology and Immunology (SSAI), German Dermatological Society (DDG), German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), German Society of Pediatrics and Adolescent Medicine (DGKJ), Society of Pediatric Pulmonology (GPP), German Respiratory Society (DGP), German Professional Association of Otolaryngologists (BVHNO), German Association of Paediatric and Adolescent Care Specialists (BVKJ), Federal Association of Pneumologists, Sleep and Respiratory Physicians (BdP), Professional Association of German Dermatologists (BVDD)

47. Epidemiologie, Krankheitslast und gesundheitsökonomische Aspekte

48. White Paper Erdnussallergie - Teil 1: Epidemiologie, Burden of Disease, gesundheitsökonomische Aspekte

Catalog

Books, media, physical & digital resources